Greenhalgh Ellis Skott 4
4 · TELA Bio, Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Greenhalgh Ellis Skott
Chief Science Officer
Transactions
- Award
Common Stock
2022-02-23+3,900→ 28,799 total - Award
Stock Option (Right to Buy)
2022-02-23+6,675→ 6,675 totalExercise: $11.75Exp: 2032-02-23→ Common Stock (6,675 underlying)
Footnotes (2)
- [F1]These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.